Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 59, Issue 6, 2010, Pages 848-853

  Hsiao, Fone Ching ^a   Wu, Chung Ze ^b   Su, Sheng Chiang ^a   Sun, Ming Tsung ^a   Hsieh, Chang Hsun ^a   Hung, Yi Jen ^a   He, Chih Tsueng ^a   Pei, Dee ^c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LEUKOCYTE COUNT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY HEIGHT; BODY WEIGHT; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; LIPIDS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; TAIWAN;

EID: 77952273043     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.10.001     Document Type: Article

References (36)

1. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
2. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
3. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
4. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
5. Smith D.O., and LeRoith D. Insulin resistance syndrome, pre-diabetes, and the prevention of type 2 diabetes mellitus. Clin Cornerstone 6 (2004) 7-6
6. Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am 2007;91(6):1063-77, viii.
7. LeRoith D. Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med 113 Suppl 6A (2002) 3S-11S
8. Sin D.D., Wu L., and Man S.F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127 (2005) 1952-1959
9. Schunemann H.J., Dorn J., Grant B.J., Winkelstein Jr. W., and Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118 (2000) 656-664
10. Schroeder E.B., Welch V.L., Couper D., et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 158 (2003) 1171-1181
11. Mannino D.M., Ford E.S., and Redd S.C. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114 (2003) 758-762
12. Engstrom G., Lind P., Hedblad B., et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 106 (2002) 2555-2560
13. Aronson D., Roterman I., Yigla M., et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 174 (2006) 626-632
14. Ochs-Balcom H.M., Grant B.J., Muti P., et al. Pulmonary function and abdominal adiposity in the general population. Chest 129 (2006) 853-862
15. Canoy D., Luben R., Welch A., et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 159 (2004) 1140-1149
16. Lazarus R., Sparrow D., and Weiss S.T. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 12 (1998) 641-645
17. Lawlor D.A., Ebrahim S., and Smith G.D. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 47 (2004) 195-203
18. Yeh H.C., Punjabi N.M., Wang N.Y., Pankow J.S., Duncan B.B., and Brancati F.L. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28 (2005) 1472-1479
19. Lin W.Y., Yao C.A., Wang H.C., and Huang K.C. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring) 14 (2006) 1654-1661
20. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152 (1995) 1107-1136
21. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
22. Reaven G.M., and Chen Y.D. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 4 (1988) 639-652
23. Engstrom G., Hedblad B., Nilsson P., Wollmer P., Berglund G., and Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 253 (2003) 574-581
24. Ford E.S., and Mannino D.M. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 27 (2004) 2966-2970
25. Attvall S., Fowelin J., Lager I., Von Schenck H., and Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Intern Med 233 (1993) 327-332
26. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163 (2003) 427-436
27. Chen C.C., Li T.C., Chang P.C., et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 57 (2008) 544-548
28. Lynch J., Helmrich S.P., Lakka T.A., et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 156 (1996) 1307-1314
29. Laaksonen D.E., Lakka H.M., Salonen J.T., Niskanen L.K., Rauramaa R., and Lakka T.A. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 25 (2002) 1612-1618
30. Lakka T.A., Laaksonen D.E., Lakka H.M., et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 35 (2003) 1279-1286
31. Vernay M., Balkau B., Moreau J.G., Sigalas J., Chesnier M.C., and Ducimetiere P. Alcohol consumption and insulin resistance syndrome parameters: associations and evolutions in a longitudinal analysis of the French DESIR cohort. Ann Epidemiol 14 (2004) 209-214
32. Mendall M.A., Strachan D.P., Butland B.K., et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 21 (2000) 1584-1590
33. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
34. Vozarova B., Weyer C., Lindsay R.S., Pratley R.E., Bogardus C., and Tataranni P.A. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 455-461
35. Ohshita K., Yamane K., Hanafusa M., et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care 27 (2004) 491-496
36. Shim W.S., Kim H.J., Kang E.S., et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 73 (2006) 284-291